Vascular regeneration by repeated infusions of basic fibroblast growth factor in a rabbit model of hind-limb ischemia

American Journal of Roentgenology

Volumn 192, Issue 6, 2009, Pages

  Seko, Ayumi ^a   Nitta, Norihisa ^a   Sonoda, Akinaga ^a   Ohta, Shinichi ^a   Takahashi, Masashi ^a   Murata, Kiyoshi ^a   Tabata, Yasuhiko ^b  

^a SHIGA UNIVERSITY OF MEDICAL SCIENCE   (Japan)

^b KYOTO UNIVERSITY   (Japan)

Author keywords

Basic fibroblast growth factor; Drug delivery system; Gelatin microspheres; Reservoir system; Vascular regeneration

Indexed keywords

GELATIN; MICROSPHERE; RECOMBINANT BASIC FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 2;

ANGIOGENESIS; ANGIOGRAPHY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; COLLATERAL CIRCULATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; FEMALE; FEMORAL ARTERY; LIMB ISCHEMIA; LOW DRUG DOSE; NONHUMAN; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RABBIT; SINGLE DRUG DOSE; TEMPERATURE; ANIMAL; DOSE RESPONSE; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HINDLIMB; INTRAARTERIAL DRUG ADMINISTRATION; ISCHEMIA; RADIOGRAPHY; REGENERATION; TREATMENT OUTCOME; VASCULARIZATION;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FEMORAL ARTERY; FIBROBLAST GROWTH FACTOR 2; HINDLIMB; INFUSIONS, INTRA-ARTERIAL; ISCHEMIA; NEOVASCULARIZATION, PHYSIOLOGIC; RABBITS; REGENERATION; TREATMENT OUTCOME;

EID: 67049125782     PISSN: 0361803X     EISSN: None     Source Type: Journal    
DOI: 10.2214/AJR.07.4013     Document Type: Article

References (34)

1. Ferreira AC. Therapeutic angiogenesis: the present and the future. Arq Bras Cardiol 2002; 78:145-147 (Pubitemid 34212370)
2. Yanagisawa-Miwa A, Uchida Y, Nakamura F, et al. Salvage of infarcted myocardium by angiogenic action of basic fibroblast growth factor. Science 1992; 257:1401-1403
3. Epstein SE, Fuchs S, Zhou YF, Baffour R, Kornowski R. Therapeutic interventions for enhancing collateral development by administration of growth factors: basic principles, early results and potential hazards. Cardiovasc Res 2001; 49:532-542 (Pubitemid 32146416)
4. Soker S, Machado M, Atala A. Systems for therapeutic angiogenesis in tissue engineering. World J Urol 2000; 18:10-18
5. Laham RJ, Garcia L, Baim DS, Post M, Simons M. Therapeutic angiogenesis using basic fibroblast growth factor and vascular endothelial growth factor using various delivery strategies. Curr Interv Cardiol Rep 1999; 1:228-233
6. Ibukiyama C. Angiogenesis: angiogenic therapy using fibroblast growth factors and vascular endothelial growth factors for ischemic vascular lesions. Jpn Heart J 1996; 37:285-300 (Pubitemid 26231957)
7. Ishii S, Koyama H, Miyata T, et al. Appropriate control of ex vivo gene therapy delivering basic fibroblast growth factor promotes successful and safe development of collateral vessels in rabbit model of hind limb ischemia. J Vasc Surg 2004; 39:629-638 (Pubitemid 38298636)
8. Kondoh K, Koyama H, Miyata T, Takato T, Hamada H, Shigematsu H. Conduction performance of collateral vessels induced by vascular endothelial growth factor or basic fibroblast growth factor. Cardiovasc Res 2004; 61:132-142 (Pubitemid 38056689)
9. Nishikage S, Koyama H, Miyata T, Ishii S, Hamada H, Shigematsu H. In vivo electroporation enhances plasmid-based gene transfer of basic fibroblast growth factor for the treatment of ischemic limb. J Surg Res 2004; 120:37-46 (Pubitemid 38686528)
10. Ohara N, Koyama H, Miyata T, et al. Adenovirus-mediated ex vivo gene transfer of basic fibroblast growth factor promotes collateral development in a rabbit model of hind limb ischemia. Gene Ther 2001; 8:837-845 (Pubitemid 32577188)
11. Hosaka A, Koyama H, Kushibiki T, et al. Gelatin hydrogel microspheres enable pinpoint delivery of basic fibroblast growth factor for the development of functional collateral vessels. Circulation 2004; 110:3322-3328 (Pubitemid 39557494)
12. Kasahara H, Tanaka E, Fukuyama N, et al. Biodegradable gelatin hydrogel potentiates the angiogenic effect of fibroblast growth factor 4 plasmid in rabbit hindlimb ischemia. J Am Coll Cardiol 2003; 41:1056-1062 (Pubitemid 36315553)
13. Kushibiki T, Tomoshige R, Fukunaka Y, Kakemi M, Tabata Y. In vivo release and gene expression of plasmid DNA by hydrogels of gelatin with different cationization extents. J Control Release 2003; 90:207-216 (Pubitemid 36694964)
14. Inoue A, Takahashi KA, Arai Y, et al. The therapeutic effects of basic fibroblast growth factor contained in gelatin hydrogel microspheres on experimental osteoarthritis in the rabbit knee. Arthritis Rheum 2006; 54:264-270 (Pubitemid 43122211)
15. Fujita M, Ishihara M, Shimizu M, et al. Therapeutic angiogenesis induced by controlled release of fibroblast growth factor-2 from injectable chitosan/non-anticoagulant heparin hydrogel in a rat hindlimb ischemia model. Wound Repair Regen 2007; 15:58-65 (Pubitemid 46146663)
16. Ohta S, Nitta N, Takahashi M, Murata K, Tabata Y. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model. Korean J Radiol 2007; 8:418-428
17. Nitta N, Ohta S, Tanaka T, et al. Gelatin microspheres: initial clinical experience for the transcatheter arterial embolization. Eur J Radiol 2008; 67:536-540
18. Takeshita S, Zheng LP, Brogi E, et al. Therapeutic angiogenesis: a single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93:662-670 (Pubitemid 24072807)
19. Baffour R, Berman J, Garb JL, Rhee SW, Kaufman J, Friedmann P. Enhanced angiogenesis and growth of collaterals by in vivo administration of recombinant basic fibroblast growth factor in a rabbit model of acute lower limb ischemia: dose-response effect of basic fibroblast growth factor. J Vasc Surg 1992; 16:181-191
20. Lazarous DF, Scheinowitz M, Shou M, et al. Effects of chronic systemic administration of basic fibroblast growth factor on collateral development in the canine heart. Circulation 1995; 91:145-153
21. Lazarous DF, Shou M, Scheinowitz M, et al. Comparative effects of basic fibroblast growth factor and vascular endothelial growth factor on coronary collateral development and the arterial response to injury. Circulation 1996; 94:1074-1082 (Pubitemid 26292864)
22. Lazarous DF, Shou M, Stiber JA, et al. Pharmacodynamics of basic fibroblast growth factor: route of administration determines myocardial and systemic distribution. Cardiovasc Res 1997; 36:78-85 (Pubitemid 27463575)
23. Lazarous DF, Shou M, Stiber JA, et al. Adenoviral-mediated gene transfer induces sustained pericardial VEGF expression in dogs: effect on myocardial angiogenesis. Cardiovasc Res 1999; 44:294-302 (Pubitemid 29474092)
24. Lazarous DF, Unger EF, Epstein SE, et al. Basic fibroblast growth factor in patients with intermittent claudication: results of a phase I trial. J Am Coll Cardiol 2000; 36:1239-1244 (Pubitemid 30760589)
25. Marui A, Tabata Y, Kojima S, et al. A novel approach to therapeutic angiogenesis for patients with critical limb ischemia by sustained release of basic fibroblast growth factor using biodegradable gelatin hydrogel: an initial report of the phase I-IIa study. Circ J 2007; 71:1181-1186 (Pubitemid 47195331)
26. Kajiguchi M, Kondo T, Izawa H, et al. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia. Circ J 2007; 71:196-201 (Pubitemid 46182692)
27. Tateishi-Yuyama E, Matsubara H, Murohara T, et al. Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 2002; 360:427-435 (Pubitemid 34884192)
28. Lopez JJ, Edelman ER, Stamler A, et al. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: a comparison of angiographic, echocardiographic and coronary flow parameters. J Pharmacol Exp Ther 1997; 282:385-390 (Pubitemid 27425565)
29. Liu Y, Sun L, Huan Y, Zhao H, Deng J. Effects of basic fibroblast growth factor microspheres on angiogenesis in ischemic myocardium and cardiac function: analysis with dobutamine cardiovascular magnetic resonance tagging. Eur J Cardiothorac Surg 2006; 30:103-107 (Pubitemid 43850313)
30. Baffour R, Garb JL, Kaufman J, et al. Angiogenic therapy for the chronically ischemic lower limb in a rabbit model. J Surg Res 2000; 93:219-229 (Pubitemid 30778196)
31. Sakakibara Y, Nishimura K, Tambara K, et al. Prevascularization with gelatin microspheres containing basic fibroblast growth factor enhances the benefits of cardiomyocyte transplantation. J Thorac Cardiovasc Surg 2002; 124:50-56
32. Tabata Y, Ikada Y. Vascularization effect of basic fibroblast growth factor released from gelatin hydrogels with different biodegradabilities. Biomaterials 1999; 20:2169-2175 (Pubitemid 29488666)
33. Yamamoto M, Ikada Y, Tabata Y. Controlled release of growth factors based on biodegradation of gelatin hydrogel. J Biomater Sci Polym Ed 2001; 12:77-88 (Pubitemid 32331415)
34. Sakakibara Y, Tambara K, Sakaguchi G, et al. Toward surgical angiogenesis using slow-released basic fibroblast growth factor. Eur J Cardiothorac Surg 2003; 24:105-111; discussion 112 (Pubitemid 36802349)